1. Home
  2. PGC vs ADCT Comparison

PGC vs ADCT Comparison

Compare PGC & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peapack-Gladstone Financial Corporation

PGC

Peapack-Gladstone Financial Corporation

HOLD

Current Price

$29.70

Market Cap

453.9M

Sector

Finance

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$4.00

Market Cap

496.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGC
ADCT
Founded
1921
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
453.9M
496.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PGC
ADCT
Price
$29.70
$4.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$35.33
$7.60
AVG Volume (30 Days)
174.9K
1.6M
Earning Date
01-27-2026
11-10-2025
Dividend Yield
0.67%
N/A
EPS Growth
6.12
N/A
EPS
1.93
N/A
Revenue
$248,809,000.00
$75,209,000.00
Revenue This Year
$27.34
$10.36
Revenue Next Year
$16.59
$3.87
P/E Ratio
$15.37
N/A
Revenue Growth
18.63
6.35
52 Week Low
$23.96
$1.05
52 Week High
$36.27
$4.80

Technical Indicators

Market Signals
Indicator
PGC
ADCT
Relative Strength Index (RSI) 71.44 49.48
Support Level $27.80 $3.15
Resistance Level $28.34 $4.32
Average True Range (ATR) 0.63 0.39
MACD 0.27 0.03
Stochastic Oscillator 91.93 62.40

Price Performance

Historical Comparison
PGC
ADCT

About PGC Peapack-Gladstone Financial Corporation

Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: